Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma [11]

Leukemia and Lymphoma

Volumn 48, Issue 7, 2007, Pages 1448-1450

  He, Simon ^a   Roberts, Andrew ^a   Ritchie, David ^a,b   Grigg, Andrew ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DOXORUBICIN; ETANERCEPT; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TACROLIMUS; VINCRISTINE;

ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ASSISTED VENTILATION; BONE MARROW BIOPSY; CASE REPORT; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DIARRHEA; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATALITY; FEVER; FOLLOW UP; GENE REARRANGEMENT; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE INFECTION; HEPATOSPLENOMEGALY; HUMAN; ILEUS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; LETHARGY; LETTER; LIVER BIOPSY; LIVER DYSFUNCTION; LUNG INFILTRATE; LYMPHOCYTIC INFILTRATION; MALE; MUCOSA INFLAMMATION; MYELOABLATIVE CONDITIONING; PANCYTOPENIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; SPLENOMEGALY; STAPHYLOCOCCUS INFECTION; T CELL LYMPHOMA; TUMOR RECURRENCE; WHOLE BODY RADIATION;

ADULT; GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVER NEOPLASMS; LYMPHOMA, T-CELL; MALE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SPLENIC NEOPLASMS;

EID: 34447574806     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701400071     Document Type: Letter

References (15)

1. Belhadj, K., Reyes, F., Farcet, J. P., Tilly, H., Bastard, C. and Angonin, R. (2003) Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: Report on a series of 21 patients. Blood, 102, pp. 4261-4269.
2. Wasik, M. A., Przybylski, G., Finan, J., Haynes, B. and Moore, H. (2000) Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients. Am J Clin Pathol, 113, pp. 487-496.
3. Navarro, J. T., Ribera, J. M., Mate, J. L., Granada, I., Junca, J. and Batlle, M. (2003) Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine. Leuk Lymphoma, 44, pp. 531-533.
4. Grigg, A. P. (2001) 2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma. Leuk Lymphoma, 42, pp. 797-799.
5. Aldinucci, D., Poletto, D., Zagonel, V., Rupolo, M., Degan, M. and Nanni, P. (2000) In vitro and in vivo effects of 2′-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies. Br J Haematol, 110, pp. 188-196.
6. Chanan-Khan, A., Islam, T., Alam, A., Miller, K. C., Gibbs, J. and Barcos, M. (2004) Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma. Leuk Lymphoma, 45, pp. 1673-1675.
7. Ooi, J., Iseki, T., Adachi, D., Yamashita, T., Tomonari, A. and Tojo, A. (2001) Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma. Haematologica, 86, p. E25.
8. Thomas, D. A., Cortes, J., O'Brien, S., Pierce, S., Faderl, S. and Albitar, M. (1999) Hyper-CVAD program in Burkitt's - Type adult acute lymphoblastic leukemia. J Clin Oncol, 17, pp. 2461-2470.
9. Grigg, A. P. and Ritchie, D. (2004) Graft-versus-lymphoma effects: clinical review, policy proposals, and immunobiology. Biol Blood Marrow Transplant, 10, pp. 579-590.
10. van Besien, K. W., de Lima, M., Giralt, S. A., Moore Jr, D. F., Khouri, I. F. and Rondon, G. (1997) Management of lymphoma recurrence after allogeneic transplantation: The relevance of graft-versus-lymphoma effect. Bone Marrow Transplant, 19, pp. 977-982.
11. Burt, R. K., Guitart, J., Traynor, A., Link, C., Rosen, S. and Pandolfino, T. (2000) Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: Evidence of a graft-versus-tumor effect. Bone Marrow Transplant, 25, pp. 111-113.
12. Corradini, P., Dodero, A., Zallio, F., Caracciolo, D., Casini, M. and Bregni, M. (2005) Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol, 23, pp. 2109-2110.
13. Yang, Y., Wang, M. and Sykes, M. (2002) Donor-derived interferon γ separates graft-versus-leukaemia effects and graft-versus-host disease induced by donor CD8 T cells. Blood, 99, pp. 4207-4215.
14. Duffner, U. A., Maeda, Y., Cooke, K. R., Reddy, P., Ordemann, R. and Liu, C. (2004) Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol, 172, pp. 7393-7398.
15. Spiotto, M. T., Rowley, D. A. and Schreiber, H. (2004) Bystander elimination of antigen loss variants in established tumors. Nat Med, 10, pp. 294-298.